The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma (Q46796219)

25 December 2017

title

The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma (English)

1 reference

25 December 2017

author name string

Gabriela Gualco

1 reference

25 December 2017

Lívia M Bacchi

1 reference

25 December 2017

Pollyanna Domeny-Duarte

1 reference

25 December 2017

Yasodha Natkunam

1 reference

25 December 2017

Carlos E Bacchi

1 reference

25 December 2017

publication date

29 June 2012

1 reference

25 December 2017

published in

Modern Pathology

1 reference

25 December 2017

volume

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

1439-1445

1 reference

25 December 2017

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Impact of gene expression profiling in lymphoma diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.119

10.1038/MODPATHOL.2012.119

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017